Interfered with RTKN2 expression could inhibit the migration and invasion of NSCLC cells by upregulating the expression of matrix metalloproteinase 9 (MMP9) and matrix metalloproteinase 2 (MMP2) (43). This evidence concerns the gene MMP2 and non-small cell lung carcinoma.